Real‐world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara‐VTd) induction and lenalidomide maintenance in transplant‐eligible multiple myeloma
Edvan de Queiroz Crusoé, Glaciano Ribeiro, João Tadeu Damian Souto Filho, Jayr Schmidt Filho et autres
br, ar (code pays fourni par la source)